News
13hon MSN
CVS Caremark ordered to pay $290M after Medicare fraud scheme exposed by former Aetna whistleblower
Whistleblower Sarah Behnke's lawsuit leads to $290 million judgment against CVS Caremark for overcharging Medicare on prescription drugs in 2013 and 2014.
A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it ...
Caremark was found liable in June, and Philadelphia federal court Chief Judge Mitchell Goldberg ordered the company to pay $95 million in damages, deferring final rulings on penalties.
CVS Caremark, CVS Health’s (NYSE:CVS) pharmacy benefit manager, has been ordered by a federal judge to pay $289.9M in damages ...
A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...
A Pennsylvania judge has ordered CVS to pay $289 million in damages as part of a long-running whistleblower case. | A ...
CVS has emerged as an outlier during the ongoing implosion observed in the healthcare insurance sector, as they drive ...
StockStory.org on MSN7d
CVS Q2 Deep Dive: Pharmacy Strength and Aetna Recovery Drive Guidance Boost
Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.4% ...
CVS Health Corp., parent of Hartford-based Aetna Inc., said Friday it has agreed to issue and sell $4 billion in notes.
CVS Health, the parent of Aetna, likes its employer health plan business but is taking a tough approach to pricing, a company executive said Friday.
The CVS-Aetna move would do just this, and would give the combined organization a competitive market advantage over healthcare providers as soon as integration is complete.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results